Figures & data
Figure 1. Graph illustrates the overview of biosynthesis of stable AgNPs from Borago officinalis leaf extract and their potential applications.
![Figure 1. Graph illustrates the overview of biosynthesis of stable AgNPs from Borago officinalis leaf extract and their potential applications.](/cms/asset/425c30ab-4f2c-446a-b160-c9d0988d3041/ianb_a_1228663_f0001_c.jpg)
Figure 3. (A and B) FE-TEM images of AgNPs, (B and C) elemental mapping results indicate distribution of elements silver.
![Figure 3. (A and B) FE-TEM images of AgNPs, (B and C) elemental mapping results indicate distribution of elements silver.](/cms/asset/2b5f13a5-e44f-43fa-b019-4b7de27fe66b/ianb_a_1228663_f0003_c.jpg)
Figure 7. Effect of different concentration of AgNPs on cell viability of RAW 264.7 macrophages cell line, A549 lung cancer cell line and HeLa cervical cancer cell line, respectively.
![Figure 7. Effect of different concentration of AgNPs on cell viability of RAW 264.7 macrophages cell line, A549 lung cancer cell line and HeLa cervical cancer cell line, respectively.](/cms/asset/b37ff8f4-1ce4-41ca-9de2-76b3e758949d/ianb_a_1228663_f0007_b.jpg)
Figure 8. (A) Zones of inhibition against Pseudomonas aeruginosa [KACC 14021], Escherichia coli [CCARM 0237], Vibrio parahaemolyticus [KACC 15069] and Staphylococcus aureus [KCTC 3881], respectively. (B) Biofilm inhibition by AgNPs against S. aureus [KCTC 3881] and P. aeruginosa [KACC 14021].
![Figure 8. (A) Zones of inhibition against Pseudomonas aeruginosa [KACC 14021], Escherichia coli [CCARM 0237], Vibrio parahaemolyticus [KACC 15069] and Staphylococcus aureus [KCTC 3881], respectively. (B) Biofilm inhibition by AgNPs against S. aureus [KCTC 3881] and P. aeruginosa [KACC 14021].](/cms/asset/a79362d5-896c-4116-8857-2fac5ad17453/ianb_a_1228663_f0008_c.jpg)
Table 1. Antimicrobial activity of the silver nanoparticles synthesized from Borago officinalis leaf extract.